{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:49:00Z","timestamp":1792450140876,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.contraception.2023.110127","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T19:14:49Z","timestamp":1690053289000},"page":"110127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Bleeding profile and safety of a levonorgestrel 13.5\u00a0mg intrauterine device versus Nova T copper 380\u00a0mm2 intrauterine device: Results of a 3-year, single-center, randomized phase 4 study"],"prefix":"10.1016","volume":"127","author":[{"given":"Josep","family":"Perell\u00f3-Cap\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Estadella-Tarriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Gich-Saladich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bail\u00f3n-Queiruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Llurba-Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Calaf-Alsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.contraception.2023.110127_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1783\/147118902101196225","article-title":"Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report","volume":"28","author":"Cox","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"5","key":"10.1016\/j.contraception.2023.110127_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0010-7824(03)00040-4","article-title":"Characteristics of menstrual problems associated with Norplant discontinuation: results of a multinational study","volume":"67","author":"Rivera","year":"2003","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2023.110127_bib3","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/01.AOG.0000435452.86108.59","article-title":"Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use","volume":"122","author":"Grunloh","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.110127_bib4","unstructured":"Faculty of Sexual & Reproductive Healthcare Clinical Guidance. Intrauterine contraception: Faculty of Sexual & Reproductive Healthcare; 2015 (amended 2019). \u3008https:\/\/www.fsrh.org\/standards-and-guidance\/documents\/ceuguidanceintrauterinecontraception\/\u3009 (accessed\u00a07\u00a0April, 2023)."},{"issue":"6","key":"10.1016\/j.contraception.2023.110127_bib5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.contraception.2016.02.024","article-title":"Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A","volume":"93","author":"Rowe","year":"2016","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2023.110127_bib6","doi-asserted-by":"crossref","first-page":"886.e1","DOI":"10.1016\/j.ajog.2020.06.023","article-title":"Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons","volume":"223","author":"Saloranta","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2023.110127_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2023.110127_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0010-7824(91)90149-A","article-title":"Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg\/day (LNg 20) and the Copper T380 Ag IUDS","volume":"44","author":"Sivin","year":"1991","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2023.110127_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0010-7824(96)00189-8","article-title":"Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system","volume":"54","author":"Suvisaari","year":"1996","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2023.110127_bib10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.contraception.2012.04.001","article-title":"Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis","volume":"86","author":"Kelekci","year":"2012","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2023.110127_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/AOG.0000000000005137","article-title":"Heavy menstrual bleeding treatment with a levonorgestrel 52-mg intrauterine device","volume":"141","author":"Creinin","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2023.110127_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.fertnstert.2011.12.003","article-title":"A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena","volume":"97","author":"Gemzell-Danielsson","year":"2012","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.contraception.2023.110127_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2019.03.044","article-title":"Comparing bleeding patterns for the levonorgestrel 52 mg, 19.5 mg, and 13.5 mg intrauterine systems","volume":"100","author":"Goldthwaite","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110127_bib14","unstructured":"Jaydess\u00ae, SmPC. \u3008https:\/\/www.medicines.org.uk\/emc\/medicine\/28672\/SPC\/Jaydess+13.5+mg+intrauterine+delivery+system\u3009 (accessed\u00a018\u00a0January, 2023)."},{"issue":"4S","key":"10.1016\/j.contraception.2023.110127_bib15","doi-asserted-by":"crossref","first-page":"S884 e1","DOI":"10.1016\/j.ajog.2019.11.1266","article-title":"Familiarity and acceptability of long-acting reversible contraception and contraceptive choice","volume":"222","author":"Paul","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.110127_bib16","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.contraception.2023.110127_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0031-1287662","article-title":"The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding","volume":"29","author":"Fraser","year":"2011","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.contraception.2023.110127_bib18","unstructured":"World Health Organization. Medical eligibility criteria for contraceptive use;\u00a02015. \u3008https:\/\/www.who.int\/publications\/i\/item\/9789241549158\u3009 (accessed\u00a023\u00a0January, 2023)."},{"key":"10.1016\/j.contraception.2023.110127_bib19","unstructured":"Nova T. 380 Product information. Bayer Healthcare. \u3008https:\/\/www.bayer.com\/sites\/default\/files\/NOVA_T_380_EN_PI.pdf\u3009\u00a0(accessed\u00a018\u00a0April, 2023)."},{"issue":"3","key":"10.1016\/j.contraception.2023.110127_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(86)90006-5","article-title":"The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction","volume":"34","author":"Belsey","year":"1986","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.contraception.2023.110127_bib21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"5834","key":"10.1016\/j.contraception.2023.110127_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/bmj.4.5834.206","article-title":"Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload","volume":"4","author":"Jacobs","year":"1972","journal-title":"Br Med J"},{"issue":"10","key":"10.1016\/j.contraception.2023.110127_bib23","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.socscimed.2012.07.005","article-title":"From bodies to lives, complainers to consumers: measuring menstrual excess","volume":"75","author":"Hasson","year":"2012","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.contraception.2023.110127_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0010-7824(87)90065-5","article-title":"Quantitative studies on menstrual blood loss in IUD users","volume":"36","author":"Andrade","year":"1987","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2023.110127_bib25","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":"Continuation and satisfaction of reversible contraception","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.contraception.2023.110127_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajog.2018.12.008","article-title":"Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis","volume":"220","author":"Sergison","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.contraception.2023.110127_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.contraception.2010.01.006","article-title":"Length of the endometrial cavity as measured by uterine sounding and ultrasonography in women of different parities","volume":"81","author":"Canteiro","year":"2010","journal-title":"Contraception"},{"issue":"7","key":"10.1016\/j.contraception.2023.110127_bib28","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/humrep\/dev102","article-title":"Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception","volume":"30","author":"Kaislasuo","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2023.110127_bib29","unstructured":"Mirena\u00ae, SmPC. \u3008https:\/\/www.pi.bayer.com\/sites\/g\/files\/vrxlpx33726\/files\/2022\u201301\/20211221_var_ap_BEC20783\u201318310_HCPI_Mirena_en_mt.pdf\u3009 (accessed\u00a018\u00a0January. 2023)."},{"issue":"4","key":"10.1016\/j.contraception.2023.110127_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.contraception.2012.09.025","article-title":"Hemoglobin and serum ferritin levels in women using copper-releasing or levonorgestrel-releasing intrauterine devices: a systematic review","volume":"87","author":"Lowe","year":"2013","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2023.110127_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.contraception.2012.08.008","article-title":"Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic review","volume":"87","author":"Tepper","year":"2013","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2023.110127_bib32","doi-asserted-by":"crossref","first-page":"50 e1","DOI":"10.1016\/j.ajog.2014.07.025","article-title":"Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction","volume":"212","author":"Diedrich","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.110127_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.contraception.2022.05.011","article-title":"Recommendations for standardization of bleeding data analyses in contraceptive studies","volume":"112","author":"Creinin","year":"2022","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2023.110127_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12905-022-01657-6","article-title":"Discontinuation rates of intrauterine contraception due to unfavourable bleeding: a systematic review","volume":"22","author":"Costescu","year":"2022","journal-title":"BMC Womens Health"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782423002214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782423002214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:23:26Z","timestamp":1757881406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782423002214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"alternative-id":["S0010782423002214"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2023.110127","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding profile and safety of a levonorgestrel 13.5\u00a0mg intrauterine device versus Nova T copper 380\u00a0mm2 intrauterine device: Results of a 3-year, single-center, randomized phase 4 study","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2023.110127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110127"}}